Ligand bound chemoattractant receptors activate the heterotrimeric G-protein G i to stimulate downstream signaling pathways to properly position lymphocytes in lymphoid organs. Here, we show how variations in the expression of a chemokine receptor and in two components in the signaling pathway, Ga i2 and RGS1, affect the output fidelity of the signaling pathway. Examination of B cells from mice with varying numbers of intact alleles of Ccr7, Rgs1, Gnai2, and Gnai3 provided the basis for these results. Loss of a single allele of either Gnai2 or Rgs1 affected CCL19 triggered chemotaxis, whereas the loss of a single allele of Ccr7, which encodes the cognate CCL19 receptor, had little effect. Emphasizing the importance of Gnai2, B cells lacking Gnai3 expression responded to chemokines better than did wild-type B cells. At an organismal level, variations in Rgs1 and Gnai2 expression affected marginal zone B-cell development, splenic architecture, lymphoid follicle size, and germinal center morphology. Gnai2 expression was also needed for the proper alignment of MOMA-1 þ macrophages and MAdCAM-1 þ endothelial cells along marginal zone sinuses in the spleen. These data indicate that chemoattractant receptors, heterotrimeric G-proteins, and RGS protein expression levels have a complex interrelationship that affects the responses to chemoattractant exposure.
Introduction
Chemoattractants help to recruit and position lymphocytes and dendritic cells in lymphoid organs and inflammatory sites. [1] [2] [3] Most lymphocyte chemoattractants and chemokines signal through G-protein-coupled receptors (GPCRs) that use the heterotrimeric G-protein G i to activate downstream effectors. 3 The binding of ligand activates receptors triggering G ai subunits to exchange GTP for GDP, resulting in the dissociation of the G a subunit from its associated G bg heterodimer. The release of G i -associated G bg subunits is necessary for triggering directional migration. 4, 5 As G a subunits possess an intrinsic GTPase activity, GTP hydrolysis leads to the re-assembly of heterotrimeric G-protein causing signaling to cease. 6, 7 Lymphocytes express two members of the Ga i subfamily, Ga i2 and Ga i3 . 8, 9 Gnai3
À/À mice were reportedly without a phenotype 10 ; however, more recently, a defect in the early seeding of the thymus by progenitors has been observed. 11 Gnai2 À/À mice exhibit defective lymphocyte chemokine receptor signaling as evidenced by depressed chemotaxis, defective homing to lymph nodes, poor adherence to lymph node high endothelial venules, and decreased motility within lymph node follicles. 8, 9 GPCRs such as chemokine receptors exist in multiple dynamic states including ligand bound, inactive, and G-protein coupled, which influence G-protein activation and subsequent downstream signaling. A recent study used parameter variation and sensitivity analysis to examine the ligand-and cell-specific parameters, which determine cellular responses in a dynamic model of GPCR signaling. 12 Not surprisingly, the most important factor was the ability of the ligand to trigger an active receptor conformation, but in addition, several cell-specific parameters strongly correlated with Gprotein activation. The three most important in rank order were G-protein concentration, Ga GTPase activity, and receptor expression. 12 Notably, these results indicate that the expression of a GPCR or G-protein several-fold above or below endogenous levels could result in responses inconsistent with those measured in endogenous systems, thereby providing a caveat for the interpretation of results from transfection studies. Also, small variations in cell-specific parameters may actually change a ligand-induced positive response to a negative one. 12 Because of the ease of assessing chemokine receptor expression by flow cytometry, immunologists have focused on those levels as a measure of chemokine responsiveness largely ignoring two other potentially important cell-specific parameters, G-protein levels and Ga GTPase activity, the later which largely depends on the presence of RGS proteins in the system. 13 Increasingly, attention has been focused on RGS proteins as a new class of pharmaceutical targets. 14 In this study, we examined the consequences of altering Ga i2 and RGS1 levels on B-cell responses to three different chemokines CXCL12, CXCL13, and CCL19 by using B cells from mice with one or two disrupted alleles of Rgs1 or Gnai2 and from mice that have various combinations of disrupted and wild-type alleles of these two genes. 8, 15 In addition, we compared the responsiveness of B cells from wildtype mice to those with only one intact allele of Ccr7. Our results indicate that the RGS1/Ga i2 ratio is an important parameter to consider in assessing B-cell chemokine responsiveness. They also provide some insights into the role of G-protein signaling in the organization of the splenic lymphoid architecture.
Results
The generation of mice for analysis and the impact of genotype on early mouse viability On a C57BL/6 background, the Rgs1 À/À mice bred and thrived similar to wild-type mice, whereas the Gnai2 À/À mice bred poorly or not at all and were maintained as heterozygotes. Litters from heterozygotic crosses generated lower than expected numbers of Gnai2 À/À mice. An earlier study had reported that Gnai2 þ /À intercrosses produced 9.7% Gnai2 À/À mice versus the expected 25%. A significant loss of Gnai2 À/À mice was reported to occur perinatally. 16 In our colony, Gnai2 À/À mice are smaller than their wild-type littermates and often die before 6 months of age of varying causes. The Gnai3 À/À mice we have used have been backcrossed 3-6 generations onto C57BL/6 background and have thrived normally. Double heterozygote crosses were bred to generate mice with the varying alleles of Rgs1 and Gnai2. The double knockout mice exhibited the same smaller stature as did the Gnai2 À/À mice ( Figure 1) . Analysis of the frequency of the different genotypes obtained from these crosses revealed an increased representation of the wild-type Gnai2 allele in the offspring. The most over represented genotype among the mice was Rgs1
þ / þ , whereas the Rgs1 allele status had little effect on the survival of the mice lacking both Gnai2 alleles. There was also the suggestion that the lack of one allele of Gnai2 negatively impacted the survival of the mice.
Varying levels of Gnai2 and Rgs1 expression affected B-cell responses to chemokines In lymphocytes, the loss of a single allele of Gnai2 reduced Ga i2 levels B50%, whereas Ga i3 levels increased a similar amount. A loss of both alleles of Gnai2 resulted in a several-fold increase in Ga i3 levels compared with controls. 8 The loss of Gnai3 has been reported to not significantly impact Ga i2 expression levels 17 and the Gnai3 À/À lymphocytes we used had similar Ga i2 expression as did littermate controls (data not shown). The disruption of a single allele of Rgs1 reduced Rgs1 mRNA expression 50% (data not shown). To determine the relative importance of Gnai2 and Rgs1 expression on chemokine receptor signaling in B lymphocytes, we prepared splenic B cells from mice with various disrupted alleles of Gnai2 and Rgs1 and tested them using standard chemotaxis assays to CXCL12, CCL19, and CXCL13. The specific migration to three different concentrations of chemokine was measured. We found that loss of one allele of Rgs1 increased responses to all three chemokines and the loss of a second allele further Chemoattractant signaling and secondary lymphoid organs IY Hwang et al increased the specific migration of B lymphocytes ( Figure 2 ). In contrast, the loss of a single allele of Gnai2 reduced responsiveness, and the additional loss of an Rgs1 allele improved the response. The B cells from the double knockout mice responded somewhat better han did the Gnai2 À/À mice arguing that the loss of Rgs1 partially compensated for the loss of Gnai2 (Figure 2 ). This is inconsistent with the known functional role of RGS1 as a Ga i2 GAP. As RGS1 is also a Gq a GAP, 18 lymphocyte chemokine receptors may couple to Gq in the absence of Ga i2 , which would explain the enhanced response in the absence of Rgs1. Gq has been shown to couple to certain chemoattractant receptors in neutrophils and dendritic cells. ] i stimulated by different chemokine concentrations with wild-type or Rgs1 À/À B cells. Wild-type or Rgs1 À/À B cells were stimulated with increasing concentrations of CXCL12 or CXCL13 as indicated. The data were analyzed with SOFT max Pro 5.2 and transformed with Graph Pad Prism and a linear regression analysis was performed to fit the curves. Each experimental value is the mean of three determinations. The experiment was performed three times with similar results. Statistical significance was calculated using Mann-Whitney t-test compared with wild type (Rgs1
and with an immature human mast cell line, where RGS13 expression was reduced.
20,21
B cells from Gnai3-deficient mice had enhanced responses to chemokines B and T lymphocyte chemotaxis, lymph nodes homing, lymph node egress, thymus egress, and positioning within lymph node organs are all sensitive to pertussis toxin treatment, which ADP ribosylates the Ga i subunits Ga i1 , Ga i2 , Ga i3 , and Go a but not Gz a . Mature B and T lymphocytes predominantly express Ga i2 and Ga i3 , but not Ga i1 . Lymphocytes lacking Ga i2 exhibit defects in all of the above with the exception of lymph node and thymus egress although sphingosine-1-phosphate (S1P)-mediated lymphocyte chemotaxis is markedly reduced in the absence of Ga i2 . 8, 9, 22 Some residual chemotaxis has been noted with the Gnai2 À/À lymphocytes; however, it is insensitive to pertussis toxin treatment. 8, 9 Together, these data argue that Ga i3 cannot mediate lymphocyte CXCR4, CXCR5, or CCR7 triggered chemotaxis. The inability of Ga i3 to substitute for Ga i2 in lymphocyte chemotaxis despite the elevated Ga i3 expression is somewhat surprising. To directly examine the role of Ga i3 in B lymphocytes, we performed chemotaxis assays and examined chemokine-induced changes in [Ca 2 þ ] i using B cells prepared from Gnai3 À/À mice. The percentage of chemokine-responsive cells from the Gnai3 À/À mice equaled or exceeded the number from controls ( Figure 4 ). In addition, the increase in [Ca 2 þ ] i elicited by the CXCL12, CXCL13, and CCL19 exceeded the levels achieved with wild-type control B cells ( Figure 4 ). These results indicate that in contrast to Ga i2 , Ga i3 is not needed for B lymphocytes to respond to chemokines, and that in its absence, Ga i2 may more efficiently couple to chemoattractant receptors.
Loss of single allele of Ccr7 minimally affected CCR7 triggered chemotaxis of B cells As we had observed changes in chemokine responsiveness in B cells lacking one allele of Rgs1 or one allele of Gnai2, we examined the consequences of the loss of one allele of Ccr7 on B-cell responsiveness to the chemoattractant Ccl19. Varying Ccr7 expression, hence Ccr7-mediated signaling, is known to help B cells position themselves properly in the B-cell follicle. 23 We isolated B cells from wild type, Ccr7 þ /À , and Ccr7 À/À littermates derived from a heterozygote cross and tested for their ability to respond in a standard chemotaxis assay. Surprisingly, we found that the lack of one allele of Ccr7, which caused a 450% reduction in CCR7 expression as assessed by flow cytometry, had only a modest impact of B-cell chemotaxis to the Ccl19. B cells from Ccr7 þ /À mice responded to low concentrations of CCL19 as well as did the wild-type control mice although they showed a modest decrease (20%) at higher concentrations of CCL19 ( Figure 5 ). As expected, B cells from Ccr7 À/À mice failed to respond to CCL19, but they responded well to CXCL12 even surpassing the wild-type B-cell responses particularly with lower concentrations of chemokine. In addition, the Ccr7 À/À B cells responded better to CXCL13 than did the wild-type B cells (data not shown). Thus, the lack of one allele of Rgs1 or Gnai2 affected Ccl19 triggered chemotaxis more than did the loss of a single allele of Ccr7. This argues that small changes in chemokine receptor expression may not be translated into significant changes in chemokine responsiveness, whereas similar magnitude changes in Gnai2 and Rgs1 expression can impact chemokine responsiveness.
Varying levels of Gnai2 and Rgs1 affected marginal zone B-cell development and the splenic architecture Earlier results had indicated that Gnai2 À/À mice had reduced number of marginal zone B cells, 24 whereas Rgs1 À/À mice had increased numbers of marginal zone B cells. 25 To examine the interaction between Rgs1 and Gnai2 in the marginal zone B-cell development, we first determined the numbers of follicular, transitional, and marginal zone B cells in wild-type mice and mice that had varying numbers of intact Gnai2 and Rgs1 alleles and in Gnai3 À/À mice ( Chemoattractant
suggesting that the number of marginal zone B cells is more sensitive to Rgs1 expression than Gnai2. In contrast to the lack of Gnai2, the loss of Gnai3 did not affect the number of marginal zone B cells.
Next, we used immunohistochemistry to examine the spleens of the different mice. B220 versus CD3 staining revealed that the spleens of the Rgs1 À/À mice contained prominent follicles with expanded B-cell zones relative to the T-cell zone, whereas the Gnai2 À/À mice had a reduction in splenic follicles and those present were small with poorly developed B-cell zones. Scattered throughout the spleen were areas of loosely organized B and T cells. The B220/CD3 immunohistochemistry with the double knockout spleens appeared similar to those from the Gnai2 À/À mice although the overall splenic architecture was even more disrupted. Although the sections from the double heterozygotes appeared most similar to those from the wild-type mice, the distinction between B-and T-cell zones was not as sharp as that in the wild-type mice and the follicles were smaller (Figure 6a ). To assess spontaneous germinal centers, we analyzed the expression of B220 versus peanut agglutinin (PNA) staining in the various sections. The spleen sections from the Rgs1 À/À mice had sixfold more spontaneous germinal centers compared with those from wild-type mice (Figures 6b-d) . Although the Gnai2 À/À mice had fewer spontaneous germinal centers, the double knockout had more than did the wild-type mice despite the severe disorganization of their splenic architecture. The double heterozygotic mice spleens had more prominent germinal centers than did those from wild-type mice. The average number of germinal centers per spleen section from the different genotype mice was as follows: 7.0 ± 2.1 wild type; 4.4 ± 1.9 Gnai2
, and 21 ± 3.1 Rgs1 À/À Gnai2 À/À To assess the organization of germinal center light and dark zones, we examined the expression of IgD versus CD35 (Figure 6c ) using the splenic sections from the different genotypes. CD35 recognizes CR1/2 and identifies follicular dendritic cells in the primary and secondary follicles and reacts with follicular dendritic cells in the germinal center light zone. 26 The constitutive germinal centers present in the spleens of wild-type mice were small with poorly developed dark zones. In contrast, in the Rgs1 À/À mice, the splenic germinal centers were often large with prominent dark zones. The germinal centers from the double knockout and Gnai2 À/À mice were disorganized with a poor segregation of the light and dark zones. The germinal center organization in double heterozygotic mice was largely intact.
To assess the splenic marginal zone region in the various mice, we analyzed sections immunostained for MAdCAM-1 and CD1d; MOMA-1 and CD1d; and IgD and IgM. 27 In wild-type spleens, the MAdCAM-1 þ cells were tightly cohesive in a thin layer encircling the follicle; however, in the spleens from the Gnai2 À/À mice and the double knockout mice, this thin layer was dispersed. In addition, in these same mice, the number of CD1d þ cells was sharply reduced (Figure 7a ). The morphology of the marginal zone sinus was intact in the sections from the Rgs1 À/À mice and from the double heterozygotes (Figure 7a ). Consistent with that result, the MOMA-1 þ cells were tightly associated with MAdCAM-1 þ cells in the wild-type mice, Rgs1 À/À and double heterozygote mice, but were no longer so in the sections from the Gnai2 À/À and double knockout mice (Figure 7b ). Examination of IgM versus IgD Immunostaining also demonstrated significant abnormalities in the spleens from the Rgs1
À/À , and double knockout mice whereas the spleens from the double heterozygotes were more normal appearing (Figure 7c ). The spleens from the Rgs1 À/À mice had an increased number of IgM high cells both within the marginal zone and in the follicle. The spleens from the Gnai2 À/À and double knockout mice had a markedly disordered marginal zone with an increased number of IgM high cells interspersed among the follicular B cells. Together, these data suggest that the ratio between RGS1/Ga i2 affects the integrity of the lymphoid architecture, spontaneous germinal center formation, and the frequency of marginal zone B cells. In addition, Ga i2 is crucial for the normal development of the marginal sinus in the spleen.
Discussion
The above findings aid our understanding of how the variation in the expression of signaling molecules affects the responses of lymphocytes to environmental cues. Modest changes in the ratio between an RGS protein and a Ga i subunit modulates the responsiveness of B lymphocytes to chemoattractants. Loss of a single allele of Rgs1 enhances chemotaxis, whereas loss of a single allele of Gnai2 reduced it. In contrast, loss of a single allele of Ccr7 had a very modest impact of B-cell chemotaxis to a cognate ligand. Disruption of both alleles of Rgs1 further increased chemokine-induced rise in [Ca 2 þ ] i and chemotaxis, whereas loss of both alleles of Gnai2 markedly attenuated the responses. Disruption of B cells responded better than did wild-type B cells to chemoattractants. Together, these results argue that the ratio between RGS proteins and Ga i2 also prominently affects B-cell chemokine responsiveness and can affect the overall lymphoid architecture. Our data and data from the analysis of other G-protein-coupled signaling pathways support the concept that cells actively modulate intracellular signaling components to help process and transmit quantitative information about their environment. Among the best studied G-protein-linked signaling pathway is a GPCR/ mitogen-activated protein kinase cascade used by haploid Saccharomyces cerevisiae yeast cells to sense and respond to pheromone secreted by cells of the opposite mating type. Signaling through this pathway is highly dependent on the levels of a yeast RGS protein Sst2 and the yeast G-protein a subunit Gpa1. [28] [29] [30] [31] Furthermore, yeast cells modulate their expression of Gpa1 and Sst2 both by transcriptional regulation and by post-translational modifications in response to pheromone. In mammalian cells, RGS proteins and Ga subunits are also subject to complex regulation. In B lymphocytes, RGS1 expression is regulated at the transcription level by antigen receptor engagement, toll receptor signaling, and by hypoxia. 18, 19, 32, 33 Although not documented for RGS1, several RGS proteins are substrates of the N-end rule pathway and RGS20 undergoes ubiquitin-mediated degradation as a consequence of G-protein activation. 34, 35 The failure of Gnai3 to compensate for the loss of Gnai2 and the modestly enhanced chemokine signaling output in the Gnai3 À/À B cells was initially puzzling as Ga i2 and Ga i3 are often thought to be interchangeable. However, emerging data from the analysis of knockout mice indicates that in some instances there may be little functional redundancy in vivo. For example, Gnai2 mice have a selective defect of parasympathetic modulation of heart rate not seen in Gnai1/Gnai3 double knockout mice. 36 Furthermore, a recent reconstitution study in Sf9 cells that showed CXCL12-induced GTPase activity in cell membrane preparations containing either Ga i1 or Ga i2 exceeded that noted with membranes containing Ga i3 and greatly exceeded those expressing Ga o , suggesting that CXCR4 preferentially couples to Ga i1 and Ga i2 . 37 An earlier study using T cells from Gnai3-deficient T cells had noted that a greater percentage of Gnai3 À/À T cells responded to CXCR3 ligands than did wild-type mice, although that was not the case for the CXCR4 ligand CXCL12. 17 Ligand bound CXCR3 bound Ga i3 , but failed to trigger nucleotide exchange, suggesting that it acted as a competitive inhibitor of Ga i2 . 17 Our overexpression studies using a human B-cell line also have suggested that Ga i2 mediates chemokine receptor signaling to chemotaxis in human B cells although they did not reveal any competitive inhibitor effect of Ga i3 (IY Hwang, unpublished data).
The opposing marginal zone B-cell phenotypes of the Rgs1 and Gnai2 knockout mice argues that GPCR signaling through Ga i2 affects the immature B-cell fate decision between follicular and marginal zone B cells. This decision is known to be influenced by extracellular inputs delivered by the B-cell antigen receptors and Notch receptors. 27, 38 A weak B-cell antigen receptor signal predisposes immature B cells towards a marginal zone B-cell phenotype, whereas a strong signal has the opposite effect. Those immature B cells that interact with Delta-like-1 (DL1), a Notch ligand present on vascular endothelial cells in the red pulp, become marginal zone B-cell precursors, whereas those that do not become T2 cells eventually yielding follicular B cells. 38 The marginal zone B-cell defect in the Gnai2 À/À mice is intrinsic to lymphoid compartment as Rag2 À/À mice reconstituted with Gnai2 À/À bone marrow also had a reduction in marginal zone B cells. 24 Weak B-cell antigen receptor signaling, impaired chemotaxis, or defects in T-cell function were considered as possible explanations for the phenotype. 24 This study favors the second explanation. A failure of Gnai2 À/À T1 B cells entering the spleen to find and interact with DL1 þ endothelial cells would provide an explanation of the phenotype, as it would bias the cells toward becoming follicular B cells. Conversely, an enhanced sensitivity of Rgs1 À/À T1 B cells to localizing signals present in the marginal zone such as S1P 39 might bias the decision towards a marginal zone fate explaining the opposite phenotype. Besides the reduction in marginal zone B cells, the morphology of the marginal zone sinuses in the spleens of the Gnai2 À/À was abnormal, resembling that previously observed in the S1pr3 À/À mice. 40 Similar to those mice, the MAd-CAM-1 þ endothelial cells did not form a cohesive ring around the follicle and the MOMA-1 þ macrophages were displaced from their usual positions along the sinus. The studies of the S1pr3 À/À mice have indicated that the initial defect is likely a failure of the MAdCAM-1 þ endothelial cells to properly encircle the follicle and that the mispositioning of the MOMA-1 þ macrophages is secondary. 40 The results presented here suggest that S1pr3 signaling in these cells depends predominantly on Ga i2 .
The lack of CCR7 or CXCR5 affects the splenic architecture, 23, [41] [42] [43] and in this study, abnormal chemokine receptor signaling output was shown to impact the organization of the spleen. In the spleen, most B cells likely enter into the periarteriolar lymphoid sheath (PALS) through the bridging channels. 44 A Ga i -dependent step is needed to cross the endothelium to enter into the PALS. 45 CXCR5-deficient B cells enter the PALS presumably using CCR7, but cannot access the B-cell zone because of failure to response to CXCL13. 41 The Gnai2 À/À B cells in the spleen exhibit a complex phenotype likely a result of both reduced CCR7 and CXCR5 signaling. Many cells apparently fail to enter into the PALS and can be found in the red pulp of the spleen. Those cells that do enter the PALS will likely respond poorly to the CCR7 localizing signals and to the CXCL13 gradient that would normally trigger their movement into the B-cell follicles. The net result likely explains the small B-cell follicles in these mice. Cell transfer experiments examining the localization of Gnai2 À/À B cells and T cells in wild-type lymph nodes are consistent with these observations. 8, 9 The Gnai2 À/À B cells and T cells that enter lymph nodes often fail to migrate away from the cortical ridge region into their respective B-cell and T-cell zones. Conversely, Rgs1
À/À B cells more rapidly localize in the B-cell zone of lymph nodes than do wild-type B cells. 8 In the Rgs1 À/À mice, the follicles in the spleen were more prominent than those in wild-type mice likely as a consequence of the enhanced responsiveness of Rgs1 The proper organization of germinal centers depends on the localization of CXCL12 in the dark zone and CXCL13 in the light zone. 46 Consistent with a need for chemokine receptor signaling for germinal center zoning, the loss of Gnai2 expression resulted in a severe disruption of the normal germinal center morphology. Modeling germinal center B-cell migration predicts that chemotaxis is needed to maintain the germinal center dark and light zone; however, the B cells must downregulate their chemokine sensitivity after transition between zones. 47 If they do not, the normal zoning of the germinal center is predicted to be disrupted. As chemokine sensitivity is predominantly a function of chemokine receptor affinity, Ga i2 levels, RGS protein expression, and receptor levels, variations in these parameters likely generate germinal center zoning. Receptor affinity is unlikely to vary during transition from centroblast to centrocyte transition arguing that the other parameters are likely more important. Centroblasts have elevated levels of CXCR4 46 and increased expression of Rgs1 and Rgs13 (J Kehrl, unpublished data). These RGS proteins may function to limit the retention of centroblasts in the dark zone, and their downregulation along with decreased CXCR4 expression contribute to increased sensitivity to CXCL13. The lack of RGS1 might enhance CXCL12 signaling abnormally retaining centroblasts in the dark zone, resulting in an expanded dark zone and overall germinal center size. Alternatively, RGS1 may affect signaling through another GPCR that functions in germinal center zoning.
In conclusion, the ratio between RGS1 and Ga i2 in B lymphocytes impacts the sensitivity of B cells to chemoattractants. The levels of RGS1 and Ga i2 are affected by environmental signals providing a mechanism by which B cells can modulate their responsiveness to chemoattractant signals independent of changes in receptor expression. The lack of RGS1 or Ga i2 causes a significant alteration in lymphoid architecture and abnormal immune responses. Both B-cell follicles and germinal center morphology are altered in the mutant mice. A more comprehensive understanding of chemoattractant signaling will require additional insights into how receptor input is matched to receptor output. Unraveling the mechanisms that dynamically control receptor, RGS protein, and G-protein expression should assist in this endeavor.
Materials and methods

Mice
The generation of Gnai2 À/À and Rgs1 À/À mice has been previously described. 8, 15, 25 The mutations have been backcrossed on to a C57BL/6 background a minimum of six times. Gnai2 À/À and Rgs1 À/À mice were interbred to generate double heterozygotes. These mice were then bred to generate littermates with the desired genotypes. The Gnai3 À/À mice have been previously described and have been backcrossed 3-6 generations onto a C57BL/6 background. 48 The Ccr7 targeted mice were purchased from Jackson Laboratories. All mice used in this study were 8-14 weeks of age. Mice were housed under specific pathogen-free conditions and used in accordance with the guidelines of the Institutional Animal Care Committee at the National Institutes of Health.
Reagents
Antibodies against mouse CD11a, CD11c, GR-1, CD4, CD8a, CD21, CD23, B220, and CCR7 were purchased from BD Pharmingen (San Diego, CA, USA). Streptavidin conjugated to phycoerythrin was also purchased from BD Pharmingen. Murine CCL19, CXCL12, and CXCL13 were purchased from R&D Systems (Minneapolis, MN, USA).
Cells
Splenic B cells were isolated by negative depletion using biotinylated antibodies to CD4, CD8, GR-1, and CDllc with Dynabeads M-280 Streptavidin (Invitrogen, Carlsbad, CA, USA) as described earlier. 25 The cell purity was 495%. Cells were placed in complete RPMI 1640 medium supplemented with 10% FCS, 2 mM L-glutamine, 100 IU ml À1 penicillin, 100 mg ml À1 streptomycin, 1 mM sodium pyruvate, and 50 mM 2-mercaptoethanol.
Chemotaxis assays
Chemotaxis assays were performed using a transwell chamber as described earlier. 25 The cells were washed twice, resuspended in complete RPMI 1640 medium, and added in a volume of 100 ml to the upper wells of a 24-well transwell plate with a 5-mm insert. Lower wells contained various doses of chemokines in 600 ml of complete RPMI 1640 medium. The number of cells that migrated to the lower well after a 2-h incubation was counted using a flow cytometer. The flow cytometric analysis of receptor expression was performed on a FACSCanto II flow cytometer (BD Biosciences, San Jose, CA, USA), and the data were analyzed using the FlowJo software (Tree Star, Inc., Ashland, OR, USA). Forward and side scatter parameters were used to gate on live cells.
Changes in [Ca
2 þ ] i Cells were seeded at 10 5 cells per 100 ml loading medium (RPMI 1640, 10% FBS) into poly-D-lysine coated 96-well black wall, clear-bottom microtiter plates (Nalgene Nunc, Rochester, NY, USA). An equal volume of assay loading buffer (FLIPR Calcium 3 assay kit, Molecular Devices, Sunnyvale, CA, USA) in Hank's balanced salt solution supplemented with 20 mM HEPES and 2 mM probenecid was added. Cells were incubated for 1 h at 37 1C before adding chemokine and then the calcium flux peak was measured using a FlexStation 3 (Molecular Devices). The data were analyzed with SOFT max Pro 5.2 (Molecular Devices). Data are shown as fluorescent counts, and the y axis was labeled as Lm1. In some instances, the data were imported into Graph Pad Prism 5 (GraphPad Software) and the log concentration of chemokine plotted versus the maximum response. The dose-response curve was generated using a non-linear fit of the data.
Immunohistochemistry
Freshly isolated spleens were snap frozen in Tissue-Tek OCT compound (Sakura Finetek, Torrance, CA, USA). Frozen OCT splenic sections (7 mm) were acetone fixed for 2 min, and dried at room temperature. Slides were rehydrated in Tris-buffered saline and stained in a humidified chamber in Tris-buffered saline/0.1% BSA/ 1% mouse serum overnight at 4 1C or 1 h at room temperature. Primary antibodies included rat anti-mouse CD45R (RA3-6B2, purified; BD Pharmingen) and Armenian hamster anti-mouse CD3e (145-2C11, purified; BD Pharmingen). Also used were PNA lectin (biotinylated; Sigma, St Louis, MO, USA), rat anti-mouse IgD (11-26c.2a, purified; BD Pharmingen), rat anti-mouse CD35 (8C12, biotinylated BD Pharmingen), rat anti-mouse CD1d (1B1, biotinylated; BD Pharmingen), rat anti-mouse mAb CD169 (MOMA-1, purified; Serotec, Raleigh, NC, USA), rat anti-mouse MAdCAM-1 (MECA-367, purified; BD Pharmingen). Biotinylated antibodies were detected with streptavidin-alkaline phosphatase (Jackson ImmunoResearch Laboratories, West Grove, PA, USA), and purified mAbs with AP-conjugated goat anti-Armenian hamster IgG (H þ L) (Jackson ImmunoResearch Laboratories) or HRP-conjugated donkey anti-rat IgG (H þ L) (Jackson ImmunoResearch Laboratories). HRP was reacted with DAB (Peroxidase Substrate Kit; Vector, Burlingame, CA, USA), and alkaline phosphatase with Fast Blue/Napthol AS-MX; Sigma-Aldrich, St Louis, MO, USA). Levamisole (Sigma-Aldrich) was used to block endogenous alkaline phosphatase activity. Slides were mounted in Crystal Mount (Electron Microscopy Sciences, Hatfield, PA, USA). For immunofluorescence, frozen acetone fixed section were stained with a mixture of FITC-conjugated F(ab') 2 goat anti-mouse IgM and rat antiIgD (11-26c.2a, purified; BD Pharmingen), 4 1C overnight. The IgD was detected with Rhodamine Red-X-conjugated F(ab') 2 donkey anti-rat (Jackson ImmunoResearch). Slides were mounted with Vectashield (Vector Labs). Images were acquired either with an Olympus BX-50 microscope equipped with a ProgRes-digital microscope camera (Jenoptik, Easthampton, MA, USA) or a Zeiss Axiovert 200 fluorescent microscope equipped with a Sensicam EM camera (Cooke, Auburn Hills, MI, USA). The number of germinal centers per spleen section was determined by Immunostaining with PNA/B220 or IgD/CD3 multiple splenic sections from two mice of each genotype.
